因为知情同意不完善导致文章撤稿:老年肺转移腺癌患者的副肿瘤性IgA血管炎

2021-12-25 MedSci原创 MedSci原创

应投稿作者Khashayar Farzam的请求,本文已被撤回,原因是作者在准备这篇文章时没有正确遵守爱荷华大学医院和诊所的患者同意程序。需要得到患者的书面同意,但只获得口头同意。

应投稿作者Khashayar Farzam的请求,本文已被撤回,原因是作者在准备这篇文章时没有正确遵守爱荷华大学医院和诊所的患者同意程序。需要得到患者的书面同意,但只获得口头同意。由于这种情况的稀有性和包含具体的案例细节,为了避免任何潜在的隐私侵犯,文章内容已被删除。作者想为他们的错误道歉,因为他们认为口头同意就足够了

This article has been retracted at the request of the submitting author, Khashayar Farzam, as the University of Iowa Hospitals & Clinics patient consent procedure was not properly followed by the authors when preparing this manuscript. Written consent was required from the patients, but only verbal consent was obtained. Due to the rarity of this condition and the inclusion of specific case details, the article content has been removed in order to avoid any potential privacy violations. The authors would like to apologize for their mistake as they believed that verbal consent was sufficient.

Cureus发表的内容是由独立的个人或组织的临床经验和/或研究的结果。Cureus不对本文发表的数据或结论的科学准确性或可靠性负责。所有在Cureus内发布的内容仅用于教育、研究和参考目的。此外,在Cureus发表的文章不应被视为合格的卫生保健专业人员的建议的合适替代品。不要忽视或避免专业的医疗建议,因为内容发表在Cureus。

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654193/

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1674591, encodeId=5d4916e45912f, content=<a href='/topic/show?id=17e194847b' target=_blank style='color:#2F92EE;'>#IgA血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9484, encryptionId=17e194847b, topicName=IgA血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74a927008194, createdName=sunyl16, createdTime=Thu Dec 08 20:25:51 CST 2022, time=2022-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263268, encodeId=5e9c1263268da, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Mon Dec 27 00:25:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503975, encodeId=e7a315039e528, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9477, encryptionId=641d94e7eb, topicName=IgA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c23f9697922, createdName=yibei, createdTime=Mon Dec 27 00:25:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512394, encodeId=40b9151239487, content=<a href='/topic/show?id=6863e314797' target=_blank style='color:#2F92EE;'>#知情同意#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73147, encryptionId=6863e314797, topicName=知情同意)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a410466491, createdName=1249862am75(暂无昵称), createdTime=Mon Dec 27 00:25:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555536, encodeId=d1ca15555364c, content=<a href='/topic/show?id=6d4f8232623' target=_blank style='color:#2F92EE;'>#肺转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82326, encryptionId=6d4f8232623, topicName=肺转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6914619384, createdName=licz0428, createdTime=Mon Dec 27 00:25:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1674591, encodeId=5d4916e45912f, content=<a href='/topic/show?id=17e194847b' target=_blank style='color:#2F92EE;'>#IgA血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9484, encryptionId=17e194847b, topicName=IgA血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74a927008194, createdName=sunyl16, createdTime=Thu Dec 08 20:25:51 CST 2022, time=2022-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263268, encodeId=5e9c1263268da, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Mon Dec 27 00:25:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503975, encodeId=e7a315039e528, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9477, encryptionId=641d94e7eb, topicName=IgA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c23f9697922, createdName=yibei, createdTime=Mon Dec 27 00:25:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512394, encodeId=40b9151239487, content=<a href='/topic/show?id=6863e314797' target=_blank style='color:#2F92EE;'>#知情同意#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73147, encryptionId=6863e314797, topicName=知情同意)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a410466491, createdName=1249862am75(暂无昵称), createdTime=Mon Dec 27 00:25:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555536, encodeId=d1ca15555364c, content=<a href='/topic/show?id=6d4f8232623' target=_blank style='color:#2F92EE;'>#肺转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82326, encryptionId=6d4f8232623, topicName=肺转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6914619384, createdName=licz0428, createdTime=Mon Dec 27 00:25:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1674591, encodeId=5d4916e45912f, content=<a href='/topic/show?id=17e194847b' target=_blank style='color:#2F92EE;'>#IgA血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9484, encryptionId=17e194847b, topicName=IgA血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74a927008194, createdName=sunyl16, createdTime=Thu Dec 08 20:25:51 CST 2022, time=2022-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263268, encodeId=5e9c1263268da, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Mon Dec 27 00:25:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503975, encodeId=e7a315039e528, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9477, encryptionId=641d94e7eb, topicName=IgA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c23f9697922, createdName=yibei, createdTime=Mon Dec 27 00:25:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512394, encodeId=40b9151239487, content=<a href='/topic/show?id=6863e314797' target=_blank style='color:#2F92EE;'>#知情同意#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73147, encryptionId=6863e314797, topicName=知情同意)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a410466491, createdName=1249862am75(暂无昵称), createdTime=Mon Dec 27 00:25:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555536, encodeId=d1ca15555364c, content=<a href='/topic/show?id=6d4f8232623' target=_blank style='color:#2F92EE;'>#肺转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82326, encryptionId=6d4f8232623, topicName=肺转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6914619384, createdName=licz0428, createdTime=Mon Dec 27 00:25:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-27 yibei
  4. [GetPortalCommentsPageByObjectIdResponse(id=1674591, encodeId=5d4916e45912f, content=<a href='/topic/show?id=17e194847b' target=_blank style='color:#2F92EE;'>#IgA血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9484, encryptionId=17e194847b, topicName=IgA血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74a927008194, createdName=sunyl16, createdTime=Thu Dec 08 20:25:51 CST 2022, time=2022-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263268, encodeId=5e9c1263268da, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Mon Dec 27 00:25:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503975, encodeId=e7a315039e528, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9477, encryptionId=641d94e7eb, topicName=IgA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c23f9697922, createdName=yibei, createdTime=Mon Dec 27 00:25:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512394, encodeId=40b9151239487, content=<a href='/topic/show?id=6863e314797' target=_blank style='color:#2F92EE;'>#知情同意#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73147, encryptionId=6863e314797, topicName=知情同意)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a410466491, createdName=1249862am75(暂无昵称), createdTime=Mon Dec 27 00:25:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555536, encodeId=d1ca15555364c, content=<a href='/topic/show?id=6d4f8232623' target=_blank style='color:#2F92EE;'>#肺转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82326, encryptionId=6d4f8232623, topicName=肺转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6914619384, createdName=licz0428, createdTime=Mon Dec 27 00:25:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1674591, encodeId=5d4916e45912f, content=<a href='/topic/show?id=17e194847b' target=_blank style='color:#2F92EE;'>#IgA血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9484, encryptionId=17e194847b, topicName=IgA血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74a927008194, createdName=sunyl16, createdTime=Thu Dec 08 20:25:51 CST 2022, time=2022-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263268, encodeId=5e9c1263268da, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Mon Dec 27 00:25:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503975, encodeId=e7a315039e528, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9477, encryptionId=641d94e7eb, topicName=IgA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c23f9697922, createdName=yibei, createdTime=Mon Dec 27 00:25:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512394, encodeId=40b9151239487, content=<a href='/topic/show?id=6863e314797' target=_blank style='color:#2F92EE;'>#知情同意#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73147, encryptionId=6863e314797, topicName=知情同意)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a410466491, createdName=1249862am75(暂无昵称), createdTime=Mon Dec 27 00:25:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555536, encodeId=d1ca15555364c, content=<a href='/topic/show?id=6d4f8232623' target=_blank style='color:#2F92EE;'>#肺转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82326, encryptionId=6d4f8232623, topicName=肺转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6914619384, createdName=licz0428, createdTime=Mon Dec 27 00:25:51 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

相关资讯

有人偷偷送你一篇6分SCI文章,你害怕吗?主动撤稿!

曾经有一篇论文摆在我眼前,但我没有丝毫印象,只能选择撤稿,即使它发表在影响因子接近 6 的期刊上。

近些年,PLOS ONE撤稿数量为什么大幅增加?

研究背景呼吸系统疾病和心血管疾病经常并存。虽然共同的风险因素是常见的,但慢性阻塞性肺疾病(COPD)与心血管疾病之间的相关性显然与这些风险因素无关。事实上,气流阻塞的严重程度与心血管疾病的发病率和死亡率之间的关系较为明确。但以气道阻塞为特征的哮喘或以肺功能受限为特征的间质性肺疾病(ILD)与心血管疾病的关系尚不清楚。此外,呼吸系统疾病与个别心血管疾病之间的相关性,包括各种不同的机制和表现,并没

神奇!论文被JCO撤稿,然后同一天再投稿,JCO重新发表

2019年2月5日,约翰·霍普金斯大学医学院Roisin M. Connolly等人在Journal of Clinical Oncology(IF=44.54)在线发表题为&ldquo

心机”教授被哈佛撤稿31篇的警示

美国哈佛大学医学院近日宣布,曾在该机构任职的皮耶罗·安韦萨有31篇论文因造假需要撤稿。这一消息震惊全球学术界,因为安韦萨曾被认为开创了心肌细胞再生的新领域,已经享誉10多年。他在心肌上动的“心机”终被揭穿,警示科研人员靠造假可能一时得意,但不可能永远欺骗所有人。

Lancet、NEJM同时撤稿遭受争议的Covid-19研究,两项研究的原始数据受到质疑!

6月4日,Lancet、NEJM各撤回了一项有争议的Covid-19研究,因为作者们无法证明原始数据的可靠性。